News & Updates

Among patients of very advanced age, those with nocturnal hypertension are at increased risk of adverse cardiovascular outcomes, as reported in a study.

Discontinuation of statins at pregnancy does not appear to contribute to increased cardiovascular (CV) risk for expectant mothers, including those at high CV risk, according to a study.

Women with polycystic ovarian syndrome (PCOS) are at an increased long-term risk of arrhythmias and are likely to receive cardiac implantable electronic device (CIED), according to a study.

Early recognition and awareness of signs and symptoms as well as genetic testing for predisposition may reduce the incidence of peripartum cardiomyopathy (PPCM), according to findings of a Hong Kong population-based study.

A substudy of the VANISH2 trial has found catheter ablation to be superior to sotalol in reducing ventricular tachycardia (VT) and VT-related events in sotalol-eligible patients. In those with more severe heart disease or VT storm, ablation demonstrates similar efficacy to amiodarone.

Patients with long COVID may experience persistent autonomic dysfunction comparable to those with pure autonomic failure, reveals a study.

The use of glucagon-like peptide-1 receptor agonists (GLP1-RAs) better protects against major adverse cardiovascular events (MACE) as compared with dipeptidyl peptidase-4 inhibitors (DPP-4is) in patients across the spectrum of kidney disease, as shown in a retrospective study.

In adults with cardiovascular‐kidney‐metabolic (CKM) syndrome, higher intake of omega‐3 polyunsaturated fatty acids (n‐3 PUFAs) has been associated with less severe CKM stage and lower mortality in new research.

In a self-controlled, longitudinal cohort study on individuals with apical periodontitis (AP), successful endodontic treatment is associated with improvements in glucose tolerance and lipid profile, suggesting a potential role in alleviating cardiometabolic disease risk.